Multivitamin for Health and Cognition

Inclusion criteria

• Participant has provided written informed consent before participating in the study after being given a full description of the study and prior to any study-specific procedures being performed.
• Participant has no significant medical diagnosis (health individuals)
• Participant takes no regular prescription medication
• Participant is not undertaking any restrictive diet (e.g. Carnivore, Low FODMAP)
• Participant agrees to adhere to guidance on fortified food intake for the duration of the study
• Participant is a male or non-pregnant female and is 18-70 years of age
• If WOCBP participant is willing to adhere to one of the following methods of contraception i) Hormonal contraception e.g. the 'pill' or an implant ii) Intrauterine device (IUD) iii) Intrauterine hormone-releasing system (IUS) iv) Hysterectomy v) Vasectomised partner vi) Sexual abstinence (if it is in line with your preferred and usual lifestyle).
• Participant can communicate well with the Investigator and to comply with the requirements for the entire study.
• Participant has capacity to understand written English.
• Participant has a body mass index (BMI) of 18.5 - 39.9kg/m2 (bounds included).
• Participant agrees to follow all pre-test preparation before L/M-HMBT testing.

Exclusion criteria

• Participant has consumed nutritional supplement in the past 3 months
• Diagnosis of any current medical condition, except visual impairment and other conditions at the discretion of the investigator
• Participated in a trial of an investigational medical product or medical device in the last 28 days.
• Females who report to be pregnant or lactating
• Prior abdominal surgery
• Unwilling to maintain a stable diet for the duration of the trial.
• Unable to comply with limiting fortified food intake to <5 portions per week for the duration of the study
• Being in the opinion of the investigator unsuitable
• Insufficient knowledge of English to complete the daily bowel diary and food diary.
• Hypersensitivity to any component of the supplement
• Hypersensitivity or known allergy to lactulose or mannitol.
• Consumption of oral antibiotics in the last 4 weeks.
• NSAIDs for 2 weeks prior to and during the entire 90 day study period. Participant should not be a chronic NSAID user (>1 day/week).
• Gastrointestinal infection in the past 4 weeks.
• IV vitamin/mineral therapy in the past 12 weeks
• Use of medical devices for the purpose of cognitive enhancement, such as neural stimulation, in the 2 weeks prior or during the study period
• Participant is involved in this study as an Investigator, sub-Investigator, study coordinator, other study staff, or Sponsor member.